Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Crossref DOI link: https://doi.org/10.1007/s40265-014-0337-y
Published Online: 2014-12-09
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Scheen, André J.
Text and Data Mining valid from 2014-12-09